Ganga Pharmaceuticals Limited announced audited standalone earnings results for the half year and full year ended March 31, 2018. For the half year, the company reported revenue from operations of INR 19.456 million against INR 11.170 million for the same period a year ago. Profit before tax was INR 1.128 million against INR 0.665 million for the same period a year ago. Net profit was INR 0.847 million against INR 0.539 million for the same period a year ago. Basic and diluted earnings per share were INR 0.21 against INR 0.13 for the same period a year ago. For the year, the company reported revenue from operations of INR 30.526 million against INR 30.104 million for the same period a year ago. Profit before tax was INR 1.266 million against INR 1.059 million for the same period a year ago. Net profit was INR 0.940 million against INR 0.742 million for the same period a year ago. Basic and diluted earnings per share were INR 0.23 against INR 0.18 for the same period a year ago.